| RS2141861740 |
GNPTG
|
Health Risk |
Pathogenic/Likely pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS2141862610 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2141862900 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2141863595 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2141863669 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2141863683 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2141863931 |
GNPTG
|
Health Risk |
Likely pathogenic |
— |
| RS2141864067 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2141864091 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2141864128 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2141864300 |
GNPTG
|
Health Risk |
Pathogenic |
— |
| RS2141864418 |
GNPTG
|
Health Risk |
Pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS2141867280 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141867643 |
CHD2
|
Health Risk |
Pathogenic |
— |
| RS2141867671 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141870681 |
TBC1D24
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2141871764 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141871936 |
TBC1D24
|
Health Risk |
Pathogenic |
— |
| RS2141871997 |
TBC1D24
|
Health Risk |
Likely pathogenic |
— |
| RS2141872114 |
TBC1D24
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2141872119 |
TBC1D24
|
Health Risk |
Pathogenic |
Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome, Developmental and epileptic encephalopathy |
| RS2141872348 |
TBC1D24
|
Health Risk |
Pathogenic |
Caused by mutation in the TBC1 domain family, member 24 |
| RS2141872499 |
TBC1D24
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2141873582 |
TBC1D24
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 65, Developmental and epileptic encephalopathy |
| RS2141873663 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141873672 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141873750 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141875717 |
TBC1D24
|
Health Risk |
Likely pathogenic |
— |
| RS2141876515 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141876542 |
CHD2
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2141876985 |
TBC1D24
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 65, Developmental and epileptic encephalopathy |
| RS2141877166 |
TBC1D24
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2141881521 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141881607 |
CHD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141881688 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141882563 |
IFT140
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 80, Retinitis pigmentosa 80 |
| RS2141888378 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141895144 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141895289 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS2141899833 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2141901872 |
NPRL3
|
Health Risk |
Likely pathogenic |
Epilepsy, familial focal |
| RS2141902503 |
NPRL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, familial focal |
| RS2141902589 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2141902592 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2141905980 |
ROGDI
|
Health Risk |
Pathogenic |
Amelocerebrohypohidrotic syndrome, Amelocerebrohypohidrotic syndrome |
| RS2141906388 |
ROGDI
|
Health Risk |
Pathogenic |
Amelocerebrohypohidrotic syndrome, Amelocerebrohypohidrotic syndrome |
| RS2141907691 |
NPRL3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Epilepsy |
| RS2141908063 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2141909104 |
NPRL3
|
Health Risk |
Likely pathogenic |
Epilepsy, familial focal |
| RS2141917789 |
MEIS2
|
Health Risk |
Pathogenic |
Cardiac malformation, cleft lip/palate |
| RS2141918318 |
MEIS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiac malformation, cleft lip/palate |
| RS2141920098 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2141925052 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2141925225 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2141925510 |
NPRL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, familial focal |
| RS2141925983 |
CIB2
|
Health Risk |
Pathogenic |
— |
| RS2141926322 |
UQCRC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex III deficiency nuclear type 5, Mitochondrial complex III deficiency nuclear type 5 |
| RS2141927529 |
PDZD9;UQCRC2
|
Health Risk |
Pathogenic |
Mitochondrial complex III deficiency nuclear type 5, Mitochondrial complex III deficiency nuclear type 5 |
| RS2141934667 |
IDH3A
|
Health Risk |
Pathogenic |
— |
| RS2141939548 |
MAPK8IP3
|
Health Risk |
Likely pathogenic |
— |
| RS2141940032 |
ERCC4
|
Health Risk |
Likely pathogenic |
Xeroderma pigmentosum, Xeroderma pigmentosum |
| RS2141942213 |
IDH3A
|
Health Risk |
Pathogenic |
— |
| RS2141944936 |
ERCC4
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group Q, Xeroderma pigmentosum |
| RS2141946055 |
NPRL3
|
Health Risk |
Likely pathogenic |
Epilepsy, familial focal |
| RS2141946068 |
ERCC4
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group Q, Fanconi anemia complementation group Q |
| RS2141946070 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2141946259 |
ERCC4
|
Health Risk |
Likely pathogenic |
Abnormality of blood and blood-forming tissues, Abnormality of blood and blood-forming tissues |
| RS2141946607 |
SCNN1G
|
Health Risk |
Pathogenic |
Liddle syndrome 2, Liddle syndrome 2 |
| RS2141950064 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2141950212 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2141950334 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2141957171 |
MAPK8IP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2141960559 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2141960644 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2141960699 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2141962944 |
ADAMTS17
|
Health Risk |
Likely pathogenic |
— |
| RS2141981312 |
NPRL3
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy, familial focal |
| RS2141993907 |
KIF7
|
Health Risk |
Likely pathogenic |
— |
| RS2141995468 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2141995568 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2142001776 |
CETP
|
Health Risk |
Pathogenic |
Hyperalphalipoproteinemia 1, Hyperalphalipoproteinemia 1 |
| RS2142004122 |
STRA6
|
Health Risk |
Likely pathogenic |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS2142018005 |
HBA2
|
Health Risk |
Pathogenic |
Heinz body anemia, Heinz body anemia |
| RS2142020387 |
SCNN1B
|
Health Risk |
Pathogenic |
Pseudohypoaldosteronism, type IB1 |
| RS2142021563 |
HBA1
|
Health Risk |
Pathogenic |
— |
| RS2142028862 |
KIF7
|
Health Risk |
Pathogenic/Likely pathogenic |
Acrocallosal syndrome, Hydrolethalus syndrome 2 |
| RS2142041186 |
IFT140
|
Health Risk |
Likely pathogenic |
— |
| RS2142050610 |
SCNN1B
|
Health Risk |
Pathogenic |
Liddle syndrome 1, Liddle syndrome 1 |
| RS2142072159 |
CAPN15
|
Health Risk |
Pathogenic |
Oculogastrointestinal-neurodevelopmental syndrome, Oculogastrointestinal-neurodevelopmental syndrome |
| RS2142076836 |
MEIOB
|
Health Risk |
Pathogenic |
Azoospermia, Azoospermia |
| RS2142079953 |
ADAMTS17
|
Health Risk |
Pathogenic |
Weill-Marchesani 4 syndrome, recessive |
| RS2142084042 |
CAPN15
|
Health Risk |
Pathogenic |
Oculogastrointestinal-neurodevelopmental syndrome, Oculogastrointestinal-neurodevelopmental syndrome |
| RS2142085042 |
CAPN15
|
Health Risk |
Pathogenic |
Oculogastrointestinal-neurodevelopmental syndrome, Oculogastrointestinal-neurodevelopmental syndrome |
| RS2142086271 |
CAPN15
|
Health Risk |
Pathogenic |
Oculogastrointestinal-neurodevelopmental syndrome, Oculogastrointestinal-neurodevelopmental syndrome |
| RS2142086863 |
FAH
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinemia type I, Tyrosinemia type I |
| RS2142090708 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2142090831 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2142097906 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS2142099151 |
IFT140
|
Health Risk |
Likely pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS2142100542 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |